Mortality reduction by post-dilution online-haemodiafiltration: A cause-specific analysis

  • Menso J. Nubé
  • , Sanne A E Peters
  • , Peter J. Blankestijn
  • , Bernard Canaud
  • , Andrew Davenport
  • , Muriel P C Grooteman*
  • , Gulay Asci
  • , Francesco Locatelli
  • , Francisco Maduell
  • , Marion Morena
  • , Ercan Ok
  • , Ferran Torres
  • , Michiel L. Bots
  • , Francesc Moreso
  • , Mercedes Pons
  • , Rosa Ramos
  • , Josep Mora-Macià
  • , Jordi Carreras
  • , Jordi Soler
  • , Josep M. Campistol
  • Alberto Martinez-Castelao, B. Insensé, C. Perez, T. Feliz, M. Barbetta, C. Soto, J. Mora, A. Juan, O. Ibrik, A. Foraster, J. Nin, A. Fernández, M. Arruche, C. Sánchez, J. Vidiella, F. Barbosa, M. Chiné, S. Hurtado, J. Llibre, A. Ruiz, M. Serra, M. Salvó, T. Poyuelo, F. Maduell, M. Carrera, N. Fontseré, M. Arias, A. Merín, L. Ribera, J. M. Galceran, J. Mòdol, E. Moliner, A. Ramirez, J. Aguilera, M. Alvarez, B. De La Torre, M. Molera, J. Casellas, G. Martín, E. Andres, E. Coll, M. Valles, C. Martínez, E. Castellote, J. M. Casals, J. Gabàs, M. Romero, A. Martinez-Castelao, X. Fulladosa, M. Ramirez-Arellano, M. Fulquet, A. Pelegrí, M. El Manouari, N. Ramos, J. Bartolomé, R. Sans, E. Fernández, F. Sarró, T. Compte, F. Marco, R. Mauri, J. Bronsoms, J. A. Arnaiz, H. Beleta, A. Pejenaute, J. Ríos, J. Lara, P. M. Ter Wee, M. A. Van Den Dorpel, M. Dorval, R. Lévesque, M. G. Koopman, C. J A M Konings, W. P. Haanstra, M. Kooistra, B. Van Jaarsveld, T. Noordzij, G. W. Feith, H. G. Peltenburg, M. Van Buren, J. J G Offerman, E. K. Hoogeveen, F. De Heer, P. J. Van De Ven, T. K. Kremer Hovinga, W. A. Bax, J. O. Groeneveld, A. T J Lavrijssen, A. M. Schrander-Van Der Meer, L. J M Reichert, J. Huussen, P. L. Rensma, Y. Schrama, H. W. Van Hamersvelt, W. H. Boer, W. H. Van Kuijk, M. G. Vervloet, I. M P M J Wauters, I. Sekse, Huseyin Toz, Ebru Sevinc Ok, Fatih Kircelli, Mumtaz Yilmaz, Ender Hur, Meltem Sezis Demirci, Cenk Demirci, Soner Duman, Ali Basci, Siddig Momin Adam, Ismet Onder Isik, Murat Zengin, Gultekin Suleymanlar, Mehmet Emin Yilmaz, Mehmet Ozkahya Pinar Ergin, Alfert Sagdic, Erkan Kayali, Can Boydak, Taskin Colak, Sihli Caliskan, Hakan Kaplan, Hasibe Ulas, Sait Kirbiyik, Hakan Berktas, Necati Dilbaz, Jean Paul Cristol, Hélène Leray-Moragues, Leïla Chenine, Marie Christine Picot, Audrey Jaussent, Claire Belloc, Mélodie Lagarrigue, Lotfi Chalabi, Alain Debure, Messaoud Ouziala, Jean Jacques Lefevre, Damien Thibaudin, Hesham Mohey, Christian Broyet, Aida Afiani, Marie Odile Serveaux, Laure Patrier, François Maurice, Jean Pierre Rivory, Philippe Nicoud, Claude Durand, Michel Normand, Bruno Seigneuric, Eric Magnant, Lynda Azzouz, Mohamed Shariful Islam, Sandor Vido, Hilaire Nzeyimana, Danièle Simonin, Yamina Azymah, Ibrahim Farah, Jean Philippe Coindre, Olivier Puyoo, Marie Hélène Chabannier, Richard Ibos, Fabienne Rouleau, Carlos Vela, Josiane Joule, François Combarnous, Cécile Turc-Baron, Francis Ducret, Philippe Pointet, Isabelle Rey, Jacky Potier, Jean Christophe Bendini, Franck Perrin, Kristian Kunz, Gaëlle Lefrancois, Angélique Colin, Sophie Parahy, Irima Dancea, Stéphanie Coupel, Angelo Testa, Philippe Brunet, Gaétan Lebrun, Dominique Jaubert, Catherine Delcroix, Frédéric Lavainne, Anne Lefebvre, Marie Paule Guillodo, Dominique Le Grignou, Assia Djema, Mehadji Maaz, Sylvie Chiron, Maxime Hoffmann, Pascale Depraetre, Atman Haddj-Elmrabet, Véronique Joyeux, Dominique Fleury, Laurence Vrigneaud, Vincent Lemaitre, Didier Aguilera, Abdallah Guerraoui, Alain Cremault, Achour Laradi, Francois Babinet
*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background. From an individual participant data (IPD) meta-analysis from four randomized controlled trials comparing haemodialysis (HD) with post-dilution online-haemodiafiltration (ol-HDF), previously it appeared that HDF decreases all-cause mortality by 14% (95% confidence interval 25; 1) and fatal cardiovascular disease (CVD) by 23% (39; 3). Significant differences were not found for fatal infections and sudden death. So far, it is unclear, however, whether the reduced mortality risk of HDF is only due to a decrease in CVD events and if so, which CVD in particular is prevented, if compared with HD. Methods. The IPD base was used for the present study. Hazard ratios and 95% confidence intervals for cause-specific mortality overall and in thirds of the convection volume were calculated using the Cox proportional hazard regression models. Annualized mortality and numbers needed to treat (NNT) were calculated as well. Results. Besides 554 patients dying from CVD, fatal infections and sudden death, 215 participants died from 'other causes', such as withdrawal from treatment and malignancies. In this group, the mortality risk was comparable between HD and ol-HDF patients, both overall and in thirds of the convection volume. Subdivision of CVD mortality in fatal cardiac, non-cardiac and unclassified CVD showed that ol-HDF was only associated with a lower risk of cardiac casualties [0.64 (0.61; 0.90)]. Annual mortality rates also suggest that the reduction in CVD death is mainly due to a decrease in cardiac fatalities, including both ischaemic heart disease and congestion. Overall, 32 and 75 patients, respectively, need to be treated by high-volume HDF (HV-HDF) to prevent one all-cause and one CVD death, respectively, per year. Conclusion. The beneficial effect of ol-HDF on all-cause and CVD mortality appears to be mainly due to a reduction in fatal cardiac events, including ischaemic heart disease as well as congestion. In HV-HDF, the NNT to prevent one CVD death is 75 per year.

Original languageEnglish
Pages (from-to)548-555
Number of pages8
JournalNephrology Dialysis Transplantation
Volume32
Issue number3
DOIs
Publication statusPublished - Mar 2017

Keywords

  • cardiovascular disease
  • convection volume
  • haemodiafiltration
  • meta-analysis
  • mortality

Fingerprint

Dive into the research topics of 'Mortality reduction by post-dilution online-haemodiafiltration: A cause-specific analysis'. Together they form a unique fingerprint.

Cite this